Uniphar
Uniphar plc, headquartered in Ireland (IE), is a leading player in the pharmaceutical and healthcare industry, specialising in the distribution of medicines and healthcare products. Founded in 1998, Uniphar has established a strong presence across Europe, particularly in Ireland and the UK, and has expanded its operations into various international markets. The company offers a diverse range of services, including supply chain management, clinical trial support, and commercialisation solutions for pharmaceutical companies. Uniphar's unique approach combines innovative technology with deep industry expertise, ensuring efficient delivery and compliance in a complex regulatory environment. Recognised for its commitment to quality and customer service, Uniphar has achieved significant milestones, positioning itself as a trusted partner in the healthcare sector. With a focus on enhancing patient outcomes, Uniphar continues to drive growth and innovation within the industry.
DitchCarbon Score
How does Uniphar's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Uniphar's score of 56 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Uniphar's reported carbon emissions
In 2024, Uniphar reported total greenhouse gas emissions of approximately 6,023,660 kg CO2e, comprising 2,833,110 kg CO2e from Scope 1 and 3,190,550 kg CO2e from Scope 2 emissions. This data reflects a commitment to transparency in their climate impact, with emissions data disclosed for both Scope 1 and Scope 2, while Scope 3 emissions data is not available. For the previous year, 2023, Uniphar's emissions were significantly higher, totalling about 884,620,000 kg CO2e when including Scope 3 emissions, which accounted for the majority of their carbon footprint. The Scope 1 and 2 emissions for 2023 were reported at approximately 6,328,900 kg CO2e. Uniphar has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 50% by 2030, using 2019 as the baseline year. Additionally, the company has pledged that 73.5% of its suppliers, based on emissions from purchased goods and services, will have science-based targets by 2027. These targets are aligned with the Science Based Targets initiative (SBTi) and are designed to contribute to limiting global warming to 1.5°C. Overall, Uniphar's emissions data and climate commitments reflect a proactive approach to sustainability within the healthcare sector, headquartered in Ireland (IE).
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 3,954,880 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 3,794,840 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - | - | 000,000,000 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Uniphar is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
